Within the nucleus, USP30 acts as a tumor suppressor by deubiquitinating LEF1 at K379/K382, disrupting the β‐catenin/LEF1 transcriptional complex and inhibiting cancer stemness, chemoresistance, and metastasis in TNBC. The gene discussed is USP30; the disease is neoplasm.